Scienture Holdings, Inc. financial data

Symbol
SCNX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2420 Brunello Trace, Lutz, FL
State of incorporation
DE
Fiscal year end
December 31
Former names
TRxADE HEALTH, INC (to 8/28/2024), TRXADE GROUP, INC. (to 5/28/2021), XCELLINK INTERNATIONAL INC. (to 1/31/2014), Bluebird Exploration Co. (to 12/10/2008)
Latest financial report
10-K - Q4 2024 - Mar 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 207 % +345%
Quick Ratio 0.09 % -99.5%
Debt-to-equity 21.7 % -91.9%
Return On Equity 19.1 %
Return On Assets 15.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.5M shares +790%
Common Stock, Shares, Outstanding 8.75M shares +867%
Entity Public Float 10.2M USD -10.9%
Common Stock, Value, Issued 87 USD +867%
Weighted Average Number of Shares Outstanding, Basic 3.38M shares +342%
Weighted Average Number of Shares Outstanding, Diluted 3.65M shares +53.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 64.9K USD -83.5%
Cost of Revenue 61K USD -82.7%
Research and Development Expense 1.25M USD
General and Administrative Expense 6.68M USD +400%
Operating Income (Loss) -14.7M USD -234%
Nonoperating Income (Expense) -4.08M USD +0.21%
Net Income (Loss) Attributable to Parent 9.07M USD +38.6%
Earnings Per Share, Basic 2.69 USD/shares
Earnings Per Share, Diluted 2.48 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.5M USD +193%
Accounts Receivable, after Allowance for Credit Loss, Current 11.1K USD +30.8%
Inventory, Net 7.88K USD -99.7%
Assets, Current 6.31M USD +129%
Deferred Income Tax Assets, Net 534K USD
Property, Plant and Equipment, Net 17.5K USD +133%
Operating Lease, Right-of-Use Asset 201K USD +5.34%
Intangible Assets, Net (Excluding Goodwill) 76.4M USD +752%
Goodwill 21.4M USD
Assets 105M USD +737%
Accounts Payable, Current 2.9M USD +98.1%
Accrued Liabilities, Current 1.31M USD +720%
Liabilities, Current 7.91M USD -31.6%
Deferred Income Tax Liabilities, Net 13.5M USD
Operating Lease, Liability, Noncurrent 156K USD -11.6%
Other Liabilities, Noncurrent 777K USD -21.4%
Liabilities 25.8M USD +115%
Retained Earnings (Accumulated Deficit) -39M USD -17.4%
Stockholders' Equity Attributable to Parent 79.1M USD +14479%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 79.1M USD +14479%
Liabilities and Equity 105M USD +737%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.2M USD -994%
Net Cash Provided by (Used in) Financing Activities -13.9M USD -2140%
Net Cash Provided by (Used in) Investing Activities 27.4M USD +8133%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 8.75M shares +867%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.35M USD +3936%
Interest Paid, Excluding Capitalized Interest, Operating Activities 62.4K USD +4474%
Deferred Tax Assets, Valuation Allowance 5.94M USD +47.3%
Operating Lease, Liability 220K USD -60%
Depreciation 500 USD -82.3%
Lessee, Operating Lease, Liability, to be Paid 262K USD -59.8%
Operating Lease, Liability, Current 63.3K USD +94.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 73.1K USD -62.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 83.5K USD -55.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 42.4K USD -58.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 56.9K USD -65.1%
Deferred Tax Assets, Operating Loss Carryforwards 1.99M USD -65.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 48.6K USD -16.7%
Operating Lease, Payments 13.6K USD
Additional Paid in Capital 118M USD +250%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.53M USD -58.4%
Interest Expense 1.23M USD +211%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%